TABLE 2.
Drugs | Probability | Severity | Observed effects | Patient outcomes | Recommendation | References |
---|---|---|---|---|---|---|
Opioids | ||||||
Methadone (Victim—CYP3A4 and CYP2C19 inhibition) | Defined | Moderate (116.8%) | Discontinuing CBD oil led to an overall decline in the methadone serum levels. Specifically, the serum methadone level was noted to be 271 ng/mL (2 days after stopping CBD), followed by 149 ng/mL (7 days after stopping CBD) and 125 ng/mL (14 days after stopping CBD) |
A case report of a 13‐year‐old patient recorded symptoms of increased fatigue and somnolence, which worsened upon admission as the pupils were minimally reactive (~2 mm). Co‐administering methadone and CBD was believed to contribute to the adverse effects reported because an improvement in the symptoms occurred with CBD withdrawal |
Implement carer education for potential cannabis–drug interactions. Provide suggestions on other supportive therapies to manage the specific symptoms that arise during methadone treatment to avoid the use of CBD | 8 |